Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01074151 · ClinicalTrials.gov registry record
The Cymbalta Pregnancy Registry
A clinical trial of Pregnancy, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- 144
- Enrollment target
- 1
- Study location
NCT01074151: Completed study of Pregnancy, sponsored by Eli Lilly and Company.
NCT01074151 is a study of Pregnancy that has completed, run by Eli Lilly and Company. The registered enrollment target is 144 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01074151, a study of Pregnancy, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are exposed to Cymbalta (duloxetine) during pregnancy. This is an observational, exposure-registration and follow-up registry.
Conditions Studied
Interventions
- DRUG duloxetine
Study Locations (1)
North Carolina
- The Cymbalta Pregnancy Registry Call Center - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2009-07 |
| Est. Completion | 2021-07-26 |
What the finished NCT01074151 record still lists
NCT01074151 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which duloxetine is the first listed.
NCT01074151 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01074151 about?
NCT01074151 is a clinical study titled "The Cymbalta Pregnancy Registry". The Cymbalta Pregnancy Registry is a U.S. based Registry designed to monitor women who are exposed to Cymbalta (duloxetine) during pregnancy. This is an observational, exposure-registration and follow-up registry.
What is the current status of trial NCT01074151?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2009-07. Estimated completion is 2021-07-26.
What conditions does trial NCT01074151 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT01074151?
The interventions under investigation include: duloxetine (DRUG).
Who is sponsoring clinical trial NCT01074151?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01074151 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01074151's enrollment target sits among peer trials
144 100th of 191 higher than 91 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia